Click Here for 5% Off Your First Aladdin Purchase!

tauroursodeoxycholic acid , CAS No.14605-22-2

  • Moligand™
  • ≥98%
Item Number
T614340
Grouped product items
SKUSizeAvailabilityPrice Qty
T614340-25μg
25μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
T614340-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$3,334.90

Basic Description

SynonymsTauroursodeoxycholic acid|14605-22-2|Tauroursodeoxycholate|TUDCA|Ursodeoxycholyltaurine|Taurursodiol|Taurolite|ursodoxicoltaurine|UR 906|Tauroursodesoxycholic acid|Ursodeoxy cholic acid|Taurursodiol [USAN]|60EUX8MN5X|CHEMBL272427|CHEBI:80774|Ur-906|Taurur
Specifications & PurityMoligand™, ≥98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Product Description

Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.

Product Properties

ALogP3.6

Associated Targets

ENPP2 Tchem Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLCO1A2 Tchem Solute carrier organic anion transporter family member 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ABCC4 Tchem Multidrug resistance-associated protein 4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NR1H4 Tclin Bile acid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ABCB11 Tchem Bile salt export pump 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GPBAR1 Tchem G-protein coupled bile acid receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PLA2G1B Tchem Phospholipase A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC10A2 Tclin Ileal sodium/bile acid cotransporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC10A1 Tclin Sodium/bile acid cotransporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
INCHI InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1
InChi Key BHTRKEVKTKCXOH-LBSADWJPSA-N
Canonical SMILES CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
Isomeric SMILES C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
WGK Germany 2
Alternate CAS 117609-50-4
PubChem CID 9848818
Molecular Weight 499.71

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

Specific Rotation[α]46 ° (C=1, EtOH)

Safety and Hazards(GHS)

WGK Germany 2

Related Documents

References

1. Cao SS, Zimmermann EM, Chuang BM, Song B, Nwokoye A, Wilkinson JE, Eaton KA, Kaufman RJ.  (2013)  The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice..  Gastroenterology,  144  (5): (989-1000.e6).  [PMID:23336977]
2. Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B et al..  (2018)  Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease..  Br J Pharmacol,  175  (3): (469-484).  [PMID:29139555]
3. Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A et al..  (2020)  Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis..  N Engl J Med,  383  (10): (919-930).  [PMID:32877582]
4. Zangerolamo L, Vettorazzi JF, Rosa LRO, Carneiro EM, Barbosa HCL.  (2021)  The bile acid TUDCA and neurodegenerative disorders: An overview..  Life Sci,  272  (3): (119252).  [PMID:33636170]
5. Paganoni S, Hendrix S, Dickson SP, Knowlton N, Macklin EA, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB et al..  (2021)  Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis..  Muscle Nerve,  63  (1): (31-39).  [PMID:33063909]

Solution Calculators